Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The current study aimed to evaluate the efficacy of selenium nanoparticles (SeNPs), combined or loaded with chitosan (COS), in broiler chickens reared under standard management protocols. The parameters under investigation were production performance, organ development, components of the intestinal barrier, and ileal microbial count. Two hundred and forty day-old chicks were raised in five groups, with each group containing eight replicates (=6/replicate). The control group received a basal diet whereas the other four groups received basal diets supplemented with SeNPs (0.5 mg/kg), COS (200 mg/kg), SeNPs+COS (0.5 mg/kg SeNPs + 200 mg/kg COS), and SeNPs-loaded COS (SeNPs-L-COS) (200 mg/kg) respectively. On day 35, two birds/replicate were sampled to collect the viscera under investigation. The results revealed that dietary inclusion of SeNPs-L-COS increased (<0.05) the body weight gain and improved (<0.05) feed conversion ratio. Similarly, SeNPs-L-COS supplementation increased (<0.05) the small intestinal villus surface area as well as the count of acidic goblet cells and intraepithelial lymphocytes when compared with the control group. Whereas the total goblet cell count was higher (<0.05) in the small intestines of both the SeNPs+COS and SeNPs-L-COS groups. Microbial analysis of ileal contents also revealed an increase (<0.05) in species count with a concurrent decrease (<0.05) in count in the SeNPs-L-COS group when compared with the COS and control groups. Based on the results of the current trial, we can conclude that supplementation with SeNPs-L-COS is a superior combination for promoting the gut health and performance of broilers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346596PMC
http://dx.doi.org/10.2141/jpsa.0210026DOI Listing

Publication Analysis

Top Keywords

200 mg/kg
12
production performance
8
broiler chickens
8
received basal
8
mg/kg cos
8
mg/kg
5
supplementation selenium
4
selenium nanoparticles-loaded
4
nanoparticles-loaded chitosan
4
chitosan improves
4

Similar Publications

Constipation is a common gastrointestinal disorder characterized by infrequent and difficult bowel movements, hard stool consistency, and delayed intestinal transit. The present study evaluated the phytochemical profile and physiological effects of the aqueous extract of beetroot leaves (AEBL) in a rat model of Loperamide (LOP)-induced constipation. Thirty-six male Wistar rats were randomly assigned to six groups (n = 6): two controls (normal and constipated) and four constipated groups receiving either increasing doses of AEBL (100, 200, or 400 mg/kg, b.

View Article and Find Full Text PDF

Background: Respiratory distress syndrome (RDS) is a leading cause of neonatal morbidity and mortality in low- and middle-income countries (LMICs). The feasibility and effectiveness of bovine versus porcine surfactants via less invasive surfactant administration (LISA) remain unstudied in LMICs. We compared clinical outcomes and cost-effectiveness of BLES versus poractant alfa in preterm infants with RDS managed with LISA.

View Article and Find Full Text PDF

Purpose: The rapid onset of anxiolytic drugs without cognitive or motor impairments remains an unmet need. This study evaluated the acute anxiolytic effects of Salvia heldreichiana essential oil in rats, measuring anxiety-related behaviors, hippocampal levels of serotonin, noradrenaline, gamma-aminobutyric acid GABA, and serum cortisol.

Method: Forty-eight male Wistar albino rats were divided into two experiments.

View Article and Find Full Text PDF

Excessive use of pesticides frequently contaminates the environment and poses health risks. This study aimed to investigate the potential hepatoprotective effect of curcumin against the toxic effects of emamectin benzoate in rats. Six groups of male Wistar rats were used: control, curcumin (Cur; 200 mg/kg), Emamectin benzoate - low dose (EMB-LD; 5 mg/kg BW), Emamectin benzoate - high dose (EMB-HD; 10 mg/kg BW), Cur plus EMB-LD, and Cur plus EMB-HD, respectively.

View Article and Find Full Text PDF

Introduction: The development of new drugs for Alzheimer's disease (AD) remains a major challenge due to the disorder's complex and multifactorial nature. 2'-Fucosyllactose (2'-FL), a human milk oligosaccharide, has demonstrated promising neuroprotective properties. However, its effects on AD-related cognitive decline are not yet fully understood.

View Article and Find Full Text PDF